Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-05-000018
Filing Date
2005-11-14
Accepted
2005-11-14 16:57:54
Documents
5
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 3RD QUARTER 2005 10Q FOR BIOSANTE PHARMACEUTICALS biosante10q3rdquarter.htm 10-Q 706686
2 CEO CERTIFICATION UNDER SECTION 302 exhibit31w1.htm EX-31.1 13589
3 CFO CERTIFICATION UNDER SECTION 302 exhibit31w2.htm EX-31.2 12136
4 CEO CERTIFICATION UNDER SECTION 906 exhibit32w1.htm EX-32.1 4786
5 CFO CERTIFICATION UNDER SECTION 906 exhibit32w2.htm EX-32.2 4691
  Complete submission text file 0001023024-05-000018.txt   743418
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 051202535
SIC: 2836 Biological Products, (No Diagnostic Substances)